(Q54507904)
Statements
A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer. (English)
Muralidhar Beeram
Ian E Krop
Howard A Burris
Sandhya R Girish
Wei Yu
Michael W Lu
Scott N Holden
30 May 2012
118
23
5733-5740
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference